Dr. Simone Krebs, MD

Dr. Krebs practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Krebs' NPI, 1861898728, was assigned on November 5, 2014. Dr. Krebs graduated from Albert Ludwigs University Faculty of Medicine in 2006. Dr. Krebs holds Texas license V0006.

Dr. Krebs' primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Krebs' primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service. Dmand AI also links Dr. Krebs to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krebs practices. Vendor and product names are available with a free account.

Nuclear medicine is Dr. Krebs' primary specialty in the NPI Registry, under taxonomy code 207U00000X. Dr. Krebs is board certified in nuclear medicine by the American Board of Nuclear Medicine. Dmand AI has Dr. Krebs' licenses on file in 3 states: Texas, New Jersey and New York.

CMS data shows 419 Medicare services from Dr. Krebs across 3 procedure codes in 2024, for 448 Medicare patients. Medicare paid $36,646 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 448 Medicare patients who saw Dr. Krebs in 2024. The largest group is 65 to 74, with 199 patients. 75% of them have cancer, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Krebs' median patient age at 67, with 62% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Krebs for performance year 2024, reported as part of a group. Dr. Krebs accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 43 papers to Dr. Krebs, published from 2007 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Positron Emission Tomography Computed Tomography, Radiopharmaceuticals and Tissue Distribution. Dr. Krebs has published most often in J Nucl Med. Dr. Krebs' most frequent co-authors are Lisa Bodei, MD, PhD, Steven M. Larson, MD and Wolfgang Weber, MD.

Dmand AI links Dr. Krebs to 2 clinical trials, 2 of them early phase 1 studies. 2 are still active or recruiting. Conditions studied include Brain Neoplasms, Histiocytosis, Sinus and Central Nervous System Neoplasms. Memorial Sloan Kettering Cancer Center sponsors the most, 2.

CMS Open Payments shows 4 general payments to Dr. Krebs from 1 drug or device company from 2023 to 2025. Honoraria make up the largest share, 66% of the total. Telix Pharmaceuticals paid the most, $3,044.

Dr. Krebs graduated from Albert Ludwigs University Faculty of Medicine in 2006.

Dr. Krebs is in network with 6 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.